Clinical trial
Carotid IMT (Intima Media Thickening) Study (0524A-041)(TERMINATED)
NCT00384293 · Merck Sharp & Dohme LLC, Industry · Terminated
Key facts
| NCT number | NCT00384293 |
|---|---|
| Title | Carotid IMT (Intima Media Thickening) Study (0524A-041)(TERMINATED) |
| Official title | A Worldwide, Double-Blind, Randomized, Placebo-Controlled Study of MK0524A 2g Coadministered With Intensive LDL-C Lowering Therapy Compared to Intensive LDL-C Lowering Therapy Alone on Carotid Artery Intima Media Thickening (cIMT) in Patients With Heterozygous Familial Hypercholesterolemia (heFH) |
| Acronym | ACHIEVE |
| Lead sponsor | Merck Sharp & Dohme LLC, Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hypercholesterolemia, Familial |
| Intervention type | Drug |
| Interventions | Comparator: niacin (+) laropiprant (MK0524A), Comparator: placebo |
| Enrollment | 937 |
| Start date | Sep 1, 2006 |
| Primary completion | Aug 1, 2008 |
| Completion | Aug 1, 2008 |
| First posted | Oct 6, 2006 |
| Last update posted | Sep 30, 2015 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: